Joseph v. Sweet

125 F. Supp. 2d 573, 2000 U.S. Dist. LEXIS 19022, 2000 WL 1910613
CourtDistrict Court, D. Massachusetts
DecidedDecember 18, 2000
DocketCIV. A. 00-11026-WGY
StatusPublished
Cited by7 cases

This text of 125 F. Supp. 2d 573 (Joseph v. Sweet) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Joseph v. Sweet, 125 F. Supp. 2d 573, 2000 U.S. Dist. LEXIS 19022, 2000 WL 1910613 (D. Mass. 2000).

Opinion

MEMORANDUM AND ORDER

YOUNG, Chief Judge.

I. INTRODUCTION

The Defendants, William H. Sweet, M.D. (“Sweet”) and Massachusetts General Hospital (“Mass General”) request this Court to refer pertinent claims in this action to a medical malpractice tribunal convened pursuant to Mass. Gen. Laws ch. 231, § 60B. The Plaintiffs, Edward A. Joseph (“Joseph”) and Marc Oddo (“Oddo”), contest the referral, claiming that it is inconsistent with the explicit goals of the Price Anderson Act. According to Joseph and Oddo, the otherwise applicable state law is preempted by the Price Anderson Act.

II. FACTUAL BACKGROUND

This cause of action arises out of experiments conducted on individuals under the care of Sweet and Mass General in the 1950s and 1960s. A brief overview of the allegations, specifically the timing of the events, is helpful to the disposition of this matter.

Nassef Joseph was sixty-four at the time he was diagnosed with a brain tumor in March 1961. Compl. ¶ 9. He underwent a craniotomy on March 27, 1961 at Mass General. At that time he was injected with a toxic substance containing boron. Several weeks later, on April 18, 1961, Nassef Joseph was transported from Mass General to MIT where he underwent a second craniotomy during which he was injected with another boron compound. In addition, he was subjected to 105 minutes of slow neutron radiation. Id. ¶ 10. The neutron flux at the brain surface was allegedly the highest given to any patient. Id. He died on August 10, 1961. Id. ¶ 11. The autopsy, performed by Dr. Sweet, de *575 termined the cause of death to be “extensive radiation necrosis of the brain.” Id.

Nearly a decade earlier, on October 12, 1953, Nicholos Oddo, then 26, entered Mass General and was diagnosed with a brain tumor. Id. ¶ 14. Four days later, he underwent a craniotomy. On November 8,1953, Nicholos Oddo was transferred to the services of Sweet to participate in studies on the toxicity of uranium and its distribution in the brain. Id. ¶ 15. As part of the study, Nicholos Oddo was injected with 5.5 mg of uranium. Id. The amounts administered to him produced a radiation dose in his bones twenty-one times higher than the maximum possible exposure rate for uranium. Id. ¶ 16. On November 13, 1953, two days after receiving the injection, Nicholos Oddo died. Id. ¶ 17.

The Plaintiffs claim that the actions of Sweet and Mass General caused substantial and unnecessary suffering to and hastened the deaths of Nicholas Oddo and Joseph Nassef. Sweet and Mass General, however, first want these actions to be assessed by a medical malpractice tribunal.

III. DISCUSSION

A. Medical Malpractice Tribunal

For the last three decades, pursuant to Mass. Gen. Laws ch. 231, § 60B, every medical malpractice action has to have been referred to a medical malpractice tribunal (the “tribunal”). The tribunal was established in 1975 as part of the Commonwealth’s response to a perceived nationwide medical malpractice insurance crisis. According to the Supreme Judicial Court, the statute was adopted “as part of a comprehensive package designed to ensure the continued availability of medical malpractice insurance at a reasonable cost.” Austin v. Boston Univ. Hosp., 372 Mass. 654, 655 n. 4, 363 N.E.2d 515 (1977). The purpose of the tribunal is to distinguish between “unfortunate medical results” and judicially cognizable claims of medical malpractice. Essentially, it is an initial screen, derailing claims with no legal merit from clogging already congested civil court dockets and increasing litigation costs.

The tribunal consists of a single justice of the Superior Court, a physician, and an attorney authorized to practice in the Commonwealth. Mass. Gen. Laws ch. 231, § 60B (1999). At the hearing before the tribunal, the plaintiff is required to make an offer of proof of the evidence supporting her claim. Id. After presentation of the evidence, the tribunal determines whether “the evidence presented if properly substantiated is sufficient to raise a legitimate question of liability appropriate for judicial inquiry or whether the plaintiffs case is merely an unfortunate medical result.” Id.

It is important to note that regardless of the tribunal’s decision, the plaintiff is free to maintain an action in court. While the purpose of the tribunal is to filter out “frivolous” claims, the tribunal does not have the power to render a final decision on the merits of the case. If the tribunal determines that the plaintiffs’ case is merely an unfortunate medical result, however, the plaintiff is required to file a $6,000 bond with the clerk of the court. 1 Id. The bond is payable to the defendant for trial costs in the event the plaintiff does not prevail in the final judgment. If the bond is not posted within thirty days of the tribunal’s decision, the statute requires that the “action shall be dismissed.” Id.

It is well established that the Rules of Decision Act requires a federal court sitting in diversity to apply the state statute at issue here. See Feinstein v. Mass. Gen. Hosp., 643 F.2d 880, 885 (1st Cir.1981). But see Seck v. Hamrang, 657 F.Supp. 1074, 1076-77 (S.D.N.Y.1987) (refusing to apply similar state law when sitting in diversity). There is, however, one caveat. The statute need not be followed if there is an “overriding federal interest in not ap *576 plying the statute.” Feinstein, 643 F.2d at 885. This is the hook on which Joseph and Oddo hang their argument. They claim that referral of this case to the tribunal is inconsistent with the Price Anderson Act (the “Act”), and as a result, the state statute is inapplicable to this case. A review of the Act is essential to determine if it establishes the necessary “overriding federal interest.”

B. Price Anderson Act

The Act was adopted in 1957 to encourage the commercial development of nuclear energy by establishing a public-private insurance pool to cover potential damages arising from nuclear occurrences. Duke Power Co. v. Carolina Env. Study Group, Inc., 438 U.S. 59, 63-65, 98 S.Ct. 2620, 57 L.Ed.2d 595 (1978); Heinrich v. Sweet, 62 F.Supp.2d 282, 296 (D.Mass.1999).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Meador v. United States
D. Massachusetts, 2024
Marino v. Turco
D. Massachusetts, 2019
Calandro v. Sedgwick Claims Mgmt. Servs., Inc.
919 F.3d 26 (First Circuit, 2019)
Lawson v. Gen. Elec. Co.
323 F. Supp. 3d 980 (E.D. Illinois, 2018)
Horan v. Cabral
D. Massachusetts, 2018
Strong v. Republic Servs., Inc.
283 F. Supp. 3d 759 (E.D. Missouri, 2017)
Lawson v. General Electric Co.
140 F. Supp. 3d 968 (N.D. California, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
125 F. Supp. 2d 573, 2000 U.S. Dist. LEXIS 19022, 2000 WL 1910613, Counsel Stack Legal Research, https://law.counselstack.com/opinion/joseph-v-sweet-mad-2000.